Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Harvoni Treatment Regimen in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

NCT02951364 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02951364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02951364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Harvoni Treatment Regimen in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
December 5, 2016
Completion date
June 11, 2021
Enrollment
1,081 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus